FOLD
Amicus Therapeutics
FOLD
FOLD
Delisted
FOLD was delisted on the 24th of April, 2026.
271 hedge funds and large institutions have $1.83B invested in Amicus Therapeutics in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 120 increasing their positions, 82 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
26% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 47
27% less capital invested
Capital invested by funds: $2.53B → $1.83B (-$695M)
Holders
271
Holding in Top 10
4
Calls
$2.4M
Puts
$1.56M
Top Buyers
| 1 | +$49.2M | |
| 2 | +$26.3M | |
| 3 | +$26.2M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$19.7M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$15.5M |
Top Sellers
| 1 | -$90.7M | |
| 2 | -$53.9M | |
| 3 | -$31.8M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$22.4M |
| 5 |
JP Morgan Chase
New York
|
-$17.3M |